Last update Jan. 18, 2021

Acne

Compatible

Safe substance and/or breastfeeding is the best option.

Trastorno cutáneo en el que hay obstrucción e inflamación de los folículos pilo-sebáceos por exceso de producción de grasa y sobreinfección bacteriana.
En el acné puede haber un exceso de andrógenos y formar parte del Síndrome del Ovario Poliquístico (SOP)

El acné puede asociarse al embarazo y al posparto y es más frecuente en primíparas (Hoefel 2020, Yang 2016, Gjerdingen 1993). Se han informado más mejorías que empeoramientos del acné durante el embarazo y el posparto y ninguna relación con la lactancia (van Pelt 1999).
El acné no contraindica lactancia en sí mismo nl lactancia empeora el acné (van Pelt 1999).

La mayoría de medicamentos, especialmente los de uso tópico, para tratar el acné son compatibles con la lactancia (Koh 2019, Murase 2015, Butler 2014, Kong 2013, Fluhr 2010


See below the information of these related products:

  • (Contraceptive combined Estrogen & Progestins) (Fairly safe. Mild or unlikely adverse effects. Compatible under certain circumstances. Follow-up recommended. Read Commentary.)
  • Adapalene (Safe substance and/or breastfeeding is the best option.)
  • Azelaic Acid (Safe substance and/or breastfeeding is the best option.)
  • Benzoyl Peroxide (Safe substance and/or breastfeeding is the best option.)
  • Cyproterone Acetate (Unsafe. Moderate/severe adverse effects. Compatible under certain circumstances. Follow-up recommended. Use safer alternative or discontinue breastfeeding from 5 to 7 T ½ . Read Commentary.)
  • Dapsone (Fairly safe. Mild or unlikely adverse effects. Compatible under certain circumstances. Follow-up recommended. Read Commentary.)
  • Doxycycline (Fairly safe. Mild or unlikely adverse effects. Compatible under certain circumstances. Follow-up recommended. Read Commentary.)
  • Erythromycin (Fairly safe. Mild or unlikely adverse effects. Compatible under certain circumstances. Follow-up recommended. Read Commentary.)
  • Glycolic Acid (Safe substance and/or breastfeeding is the best option.)
  • Isotretinoin (Unsafe. Moderate/severe adverse effects. Compatible under certain circumstances. Follow-up recommended. Use safer alternative or discontinue breastfeeding from 5 to 7 T ½ . Read Commentary.)
  • Laser Rays (Safe substance and/or breastfeeding is the best option.)
  • Melitracen Hydrochloride (Fairly safe. Mild or unlikely adverse effects. Compatible under certain circumstances. Follow-up recommended. Read Commentary.)
  • Minocycline (Fairly safe. Mild or unlikely adverse effects. Compatible under certain circumstances. Follow-up recommended. Read Commentary.)
  • Netupitant (Fairly safe. Mild or unlikely adverse effects. Compatible under certain circumstances. Follow-up recommended. Read Commentary.)
  • Nicotine Replacement Therapy (NRT) (Safe substance and/or breastfeeding is the best option.)
  • Polycystic Ovary Syndrome (Safe substance and/or breastfeeding is the best option.)
  • Salicylic Acid (Safe substance and/or breastfeeding is the best option.)
  • Spironolactone (Safe substance and/or breastfeeding is the best option.)
  • Tazarotene (Fairly safe. Mild or unlikely adverse effects. Compatible under certain circumstances. Follow-up recommended. Read Commentary.)
  • Tretinoin (systemic use) (Unsafe. Moderate/severe adverse effects. Compatible under certain circumstances. Follow-up recommended. Use safer alternative or discontinue breastfeeding from 5 to 7 T ½ . Read Commentary.)
  • Tretinoin (topical use) (Safe substance and/or breastfeeding is the best option.)
  • Zinc (systemic administration) (Safe substance and/or breastfeeding is the best option.)

Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.

Jose Maria Paricio, Founder & President of APILAM/e-Lactancia

Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.

Thank you for helping to protect and promote breastfeeding.

José María Paricio, founder of e-lactancia.
DONATE NOW

Other names

Acne is also known as


Group

Acne belongs to this group or family:

References

  1. Hoefel IDR, Weber MB, Manzoni APD, Lovato BH, Bonamigo RR. Striae Gravidarum, Acne, Facial Spots, and Hair Disorders: Risk Factors in a Study with 1284 Puerperal Patients. J Pregnancy. 2020 May 19;2020:8036109. Abstract
  2. Koh YP, Tian EA, Oon HH. New changes in pregnancy and lactation labelling: Review of dermatologic drugs. Int J Womens Dermatol. 2019 May 16;5(4):216-226. Abstract Full text (link to original source)
  3. Yang CC, Huang YT, Yu CH, Wu MC, Hsu CC, Chen W. Inflammatory facial acne during uncomplicated pregnancy and post-partum in adult women: a preliminary hospital-based prospective observational study of 35 cases from Taiwan. J Eur Acad Dermatol Venereol. 2016 Oct;30(10):1787-1789. Abstract
  4. Murase J. Safe Skin Care During Pregnancy and Breastfeeding. Fact Sheet. For the media. American Academy of Dermatology. 2015 Full text (link to original source) Full text (in our servers)
  5. Butler DC, Heller MM, Murase JE. Safety of dermatologic medications in pregnancy and lactation: Part II. Lactation. J Am Acad Dermatol. 2014 Mar;70(3):417.e1-10; quiz 427. Abstract
  6. Kong YL, Tey HL. Treatment of acne vulgaris during pregnancy and lactation. Drugs. 2013 Jun;73(8):779-87. Abstract
  7. Fluhr JW, Degitz K. [Antibiotics, azelaic acid and benzoyl peroxide in topical acne therapy]. J Dtsch Dermatol Ges. 2010 Abstract
  8. Worret WI, Fluhr JW. [Acne therapy with topical benzoyl peroxide, antibiotics and azelaic acid]. J Dtsch Dermatol Ges. 2006 Abstract
  9. van Pelt HP, Juhlin L. Acne conglobata after pregnancy. Acta Derm Venereol. 1999 Mar;79(2):169. No abstract available. Abstract
  10. Gjerdingen DK, Froberg DG, Chaloner KM, McGovern PM. Changes in women's physical health during the first postpartum year. Arch Fam Med. 1993 Mar;2(3):277-83. Abstract

Total visits

31,027

Help us improve this entry

How to cite this entry

Do you need more information or did not found what you were looking for?

   Write us at elactancia.org@gmail.com

e-lactancia is a resource recommended by El Parto Es Nuestro of Spain

Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM